Glucagon-like peptides agonists promote maturation of intestinal organoids derived from neonates with necrotizing enterocolitis
Topic overview
This study demonstrates that glucagon-like peptide (GLP) agonists enhance maturation of intestinal organoids derived from premature infants with necrotizing enterocolitis (NEC). Using patient-derived organoid models, researchers found GLP treatment improved both injured and uninjured intestinal tissue morphology, suggesting potential therapeutic applications for NEC management in preterm neonates.
Key takeaways
- GLP agonists enhance maturation of intestinal organoids from both injured and uninjured neonatal tissue in NEC patients
- Injured intestinal organoids from NEC patients show decreased budding compared to uninjured tissue from the same patient
- Patient-derived intestinal organoids provide a viable ex vivo model for studying NEC pathogenesis and testing therapeutics
- Premature infants before 26 weeks gestation have underdeveloped intestinal hormonal activity, increasing NEC susceptibility
- GLP signaling modulation represents a potential precision medicine approach for NEC treatment pending in vivo validation
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Glucagon-like peptides agonists promote maturation of intestinal organoids derived from neonates with necrotizing enterocolitis. GlobalCastMD Medical Library. 2025-01-19. https://dev.library.globalcastmd.com/article/9665?via_space=staycurrentmd
Comments